Pfizer, Inc.

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:34 2024-05-24 pm EDT			After market 07:59:08 pm
28.88 ^USD	+0.66%		28.98	+0.33%

May. 24	Novavax awaits FDA decision on whether its next COVID shot can be offered in US	RE
May. 23	Cogent Reports Positive Cancer Combo Treatment Trial Data; Names Commercial Chief	MT

PFIZER INC : Buy rating from DZ Bank

May 02, 2024 at 03:53 pm EDT

DZ Bank analyst Elmar Kraus maintains his Buy rating on the stock.

Latest news about Pfizer, Inc.

Novavax awaits FDA decision on whether its next COVID shot can be offered in US	May. 24	RE
Cogent Reports Positive Cancer Combo Treatment Trial Data; Names Commercial Chief	May. 23	MT
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney...	May. 23
Pfizer: initiative against antibiotic resistance in Malawi	May. 23	CF
The market is good to go until Nvidia’s next quarterly results	May. 23
News Highlights : Top Company News of the Day - Thursday at 9 AM ET	May. 23	DJ
BioMérieux, Pfizer to Collaborate on Antimicrobial Resistance Initiative in Malawi	May. 23	MT
Asymchem Laboratories Buys Pfizer's Former UK Site; Hong Kong Shares Slide 3%	May. 23	MT
News Highlights : Top Company News of the Day - Thursday at 3 AM ET	May. 23	DJ
News Highlights : Top Company News of the Day - Thursday at 1 AM ET	May. 23	DJ
News Highlights : Top Company News of the Day - Wednesday at 11 PM ET	May. 22	DJ
News Highlights : Top Company News of the Day - Wednesday at 9 PM ET	May. 22	DJ
Health Care Up as Vaccine Makers Gain - Health Care Roundup	May. 22	DJ
US IS IN 'ACTIVE CONVERSATIONS' WITH MRNA VACCINE MAKERS PFIZER…	May. 22	RE
Sector Update: Health Care Stocks Slightly Higher Late Afternoon	May. 22	MT
Sector Update: Health Care	May. 22	MT
Pfizer to Cut Costs in Multi-Year Effort -- Update	May. 22	DJ
Pfizer Looks for $1.5 Billion in Savings by 2027, Expects One-Time Cost Reduction Charge of $1.7 Billion	May. 22	MT
Pfizer to Cut Costs in Multi-Year Effort	May. 22	DJ
Pfizer targets $1.5 bln in savings by 2027 as it streamlines operations	May. 22	RE
Pfizer launches multi-year cost-cuts program, eyes $1.5 bln in savings	May. 22	RE
Pfizer: RSV vaccine launched in Canada	May. 22	CF
Sector Update: Health Care Stocks Advance Late Afternoon	May. 21	MT
China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK	May. 21	DJ
Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon	May. 21	MT

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).

Sector

Pharmaceuticals

Calendar

2024-05-31 - American Society of Clinical Oncology Annual Meeting - Abstract No: LBA8503

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs

October 31, 2023 at 04:50 pm EDT

More Strategies

Ratings for Pfizer, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

28.88 USD

Average target price

31.94 USD

Spread / Average Target

+10.59%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PFIZER, INC.	+0.31%	163B
ELI LILLY AND COMPANY	+38.51%	728B
NOVO NORDISK A/S	+33.05%	603B
JOHNSON & JOHNSON	-6.23%	360B
MERCK & CO., INC.	+18.78%	332B
ABBVIE INC.	+1.35%	279B
ASTRAZENECA PLC	+16.00%	244B
NOVARTIS AG	+8.09%	207B
ROCHE HOLDING AG	-5.77%	205B
AMGEN INC.	+6.19%	164B

Other Pharmaceuticals

Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

PFIZER INC : Buy rating from DZ Bank

Latest news about Pfizer, Inc.

Chart Pfizer, Inc.

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Pfizer, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals